Evidence map›Paper›PMID 30661852›Full record

ArticleStructure (London, England : 1993)2019

Structure-Guided Exploration of SDS22 Interactions with Protein Phosphatase PP1 and the Splicing Factor BCLAF1.

Ewald Heroes, Gerd Van der Hoeven, Meng S Choy, Javier Del Pino Garcia, Mónica Ferreira, Mieke Nys, Rita Derua, Monique Beullens, Chris Ulens, Wolfgang Peti and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Structure (London, England : 1993), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Alternating binding and p97-mediated dissociation of SDS22 and I3 recycles active PP1 between holophosphatases.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  4. Article
  5. Article
  6. Open biology · 2022
    Article
  7. Article
  8. Article
  9. SDS22 selectively recognizes and traps metal-deficient inactive PP1.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Ewald HeroesLaboratory of Biosignaling & Therapeutics, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium; Biomolecular Architecture, Department of Chemistry, KU Leuven, Leuven, Belgium.
Gerd Van der HoevenLaboratory of Biosignaling & Therapeutics, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
Meng S ChoyDepartment of Chemistry and Biochemistry, University of Arizona, Tucson, AZ 85718, USA.
Javier Del Pino GarciaLaboratory of Biosignaling & Therapeutics, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
Mónica FerreiraLaboratory of Biosignaling & Therapeutics, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
Mieke NysLaboratory of Structural Neurobiology, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
Rita DeruaProtein Phosphorylation & Proteomics Lab, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
Monique BeullensLaboratory of Biosignaling & Therapeutics, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
Chris UlensLaboratory of Structural Neurobiology, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
Wolfgang PetiDepartment of Chemistry and Biochemistry, University of Arizona, Tucson, AZ 85718, USA.
Luc Van MeerveltBiomolecular Architecture, Department of Chemistry, KU Leuven, Leuven, Belgium.
Rebecca PageDepartment of Chemistry and Biochemistry, University of Arizona, Tucson, AZ 85718, USA. Electronic address: rebeccapage@email.arizona.edu.
Mathieu BollenLaboratory of Biosignaling & Therapeutics, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium. Electronic address: mathieu.bollen@kuleuven.be.
KU Leuven · BEUniversity of Arizona · US

Funding

The Regulation of PP1 in the NucleusR01GM098482 · NIGMS · UNIVERSITY OF ARIZONA · PI PAGE, REBECCA · 2011 to 2019
$2.8M
Supplement for "Serine/Threonine Phosphatases in Neurological Diseases"R01NS091336 · NINDS · UNIVERSITY OF ARIZONA · PI PAGE, REBECCA, PETI, WOLFGANG · 2015 to 2019
$1.8M
Protein Phosphatase 1 Holoenzyme Formation and Subunit ExchangeR01GM134683 · NIGMS · UNIVERSITY OF ARIZONA · PI PETI, WOLFGANG · 2019 to 2020
$564k
NIGMS NIH HHS R01 GM098482NIGMS NIH HHS R01 GM134683NINDS NIH HHS R01 NS091336
6 · The paper itself

Abstract

SDS22 is an ancient regulator of protein phosphatase-1 (PP1). Our crystal structure of SDS22 shows that its twelve leucine-rich repeats adopt a banana-shaped fold that is shielded from solvent by capping domains at its extremities. Subsequent modeling and biochemical studies revealed that the concave side of SDS22 likely interacts with PP1 helices α5 and α6, which are distal from the binding sites of many previously described PP1 interactors. Accordingly, we found that SDS22 acts as a "third" subunit of multiple PP1 holoenzymes. The crystal structure of SDS22 also revealed a large basic surface patch that enables binding of a phosphorylated form of splicing factor BCLAF1. Taken together, our data provide insights into the formation of PP1:SDS22 and the recruitment of additional interaction proteins, such as BCLAF1.

Indexed as

Binding SitesHumansModels, MolecularPhosphorylationProtein BindingProtein Phosphatase 1Protein Structure, SecondaryRepressor ProteinsTumor Suppressor ProteinsBCLAF1 protein, humanPPP1R7 protein, humanProtein Phosphatase 1Repressor ProteinsTumor Suppressor ProteinsBCLAF1leucine-rich repeatsMYPT1PNUTSprotein dephosphorylationprotein phosphatase-1RepoManSDS22THRAP3

Identifiers

PMID30661852
PMCPMC6538287
OpenAlexW2911154369

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.